Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;31(5):NP19-NP22.
doi: 10.1177/1120672120921373. Epub 2020 Apr 27.

Bilateral subfoveal serous detachment following Cisplatin chemotherapy

Affiliations
Case Reports

Bilateral subfoveal serous detachment following Cisplatin chemotherapy

Boon Lin Teh et al. Eur J Ophthalmol. 2021 Sep.

Abstract

A 74-year-old gentleman with a background of metastatic pancreatic neuroendocrine tumour on combination chemotherapy of Cisplatin and Etoposide presented with a 3-week history of bilateral visual loss. Snellen visual acuity was right 6/9 and left 6/60. Fundus examination revealed clear media with isolated macular oedema in both eyes. Optical coherence tomography of the maculae showed localised bilateral subfoveal serous detachments. Cisplatin was thought to be the causative agent and was withheld following discussion with the treating Oncology team. Eight weeks after withholding Cisplatin, his vision improved with complete resolution of the subretinal fluid. To the authors' knowledge, this is the first report to have illustrated bilateral subfoveal serous detachment caused by Cisplatin which resolved completely with cessation of offending drug.

Keywords: Cisplatin; chemotherapy; ocular toxicity; subfoveal serous detachment.

PubMed Disclaimer

Publication types

LinkOut - more resources